Advances in tissue engineering, bioprinting, and body-on-a-chip technologies: An update for regenerative medicine workforce development. This webinar provides an update on these technologies and how they will shape the work of skilled technical graduates in the future.
Regenerative medicine is emerging in biomedical research, clinical translation, and scaled biomanufacturing. To best prepare their students to join this workforce, community college and baccalaureate bioscience programs should review their curriculums to ensure this important field is being incorporated. In this webinar you will find the following: Regenerative Medicine Approvals Need a Workforce – Jim DeKloe, Solano Community College Incorporating Gene Therapy Skills and Knowledge into Existing Courses and Programs – Margaret Bryans, Montgomery County Community College Immunofluorescence in
A video prepared for the InnovATE BIO Leadership Institute. Covers the differences between startups and large companies, how startups need to evaluate customer demand, and how these approaches can be applied to developing grant proposals and new biotech education programs.
This video is about finding links to employer job pages Biotech-Careers.org. This material is based upon work supported by the National Science Foundation under DUE 1800909
Jan-Philip Prahl of the Advanced Biofuels and Bioproducts Process Development Unit (ABPDU) speaks about downstream processing considerations at the pilot scale (300-L). The talk covers cell separation (centrifugation), protein concentration (TFF), and diafiltration (UF/DF).
The Laney College biomanufacturing program hosted Danny Grannick from Oxford Nanopore in their first webinar during the COVID-19 shelter-in-place. Danny begins with an overview of sequencing technology and then turns to applications to health, biopharma, and the fight against the coronavirus. Here is the full agenda: Sequencing and Genomics - brief overview on technology roadmaps and platform differences Oxford Nanopore - brief overview Applications - BioPharma, SynBio, the role of sequencing for COVID-19 Where sequencing and genomics is headed - decentralization of sequencing technologies and
Josiah Zayner talks about his origin story as a biohacker and why he believes tools like CRISPR should be made accessible to all. For more info, go to https://www.the-odin.com. This is part I. Go to part II.
